Method and apparatus for continuously monitoring the concentration of a metabolyte

• US 5,640,954 A
• Filed: 05/05/1995
• Issued: 06/24/1997
• Est. Priority Date: 01/19/1994
• Status: Expired due to Fees

• Current Assignee: Institut Fuer Diabetes-Technologie Gemeinnuetzige Forschungs- Und Entwicklungsgesellschaft Mbh An Der Universitaet Ulm, Institut FUER Diabetes-Technologie Gemeinnuetzige Forschungs-Und EntwicklungsGmbH An Der Universitaet ULM
• Original Assignee: Ernst Pfeiffer, Fabio Sternberg
• Inventors: Pfeiffer, Ernst, Sternberg, Fabio
• Primary Examiner(s): Sykes, Angela D.
• Assistant Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US08/435,382
• Time in Patent Office: 781 Days
• Field of Search: 128/632, 128/635, 604/890.1, 604/891.1, 604/31, 604/48, 604/45, 604/50, 604/51, 204/403, 204/415
• US Class Current: 600/345
• CPC Class Codes: A61B 5/14528 invasively
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
• CPC Class Codes: C12Q 1/005 involving specific analytes or enzymes including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence

Abstract

The present invention is directed to a method and an apparatus for continuously monitoring the concentration of a metabolite, such as glucose or lactic acid, in biological tissue, in which a perfusion fluid is fed to a microdialysis probe implanted in the subcutaneous tissue and removed therefrom as dialysate after enrichment with the metabolites contained in the lymph. An enzyme is added to the dialysate and/or perfusion fluid, and the concentration of the metabolite in the dialysate is determined under the selective effect of the enzyme at a measuring point which is positioned ex vivo, using an electrochemical sensor. The enzyme is added to the dialysate in the form of a continuous enzyme solution flow upstream of the measuring point and in dependence of the throughput of the microdialysis probe.

Claims

1. A method for continuously monitoring the concentration of a metabolite in biological tissue comprising the steps of:

implanting a microdialysis probe in subcutaneous tissue so that it contacts with lymph contained in the subcutaneous tissue;

feeding a perfusion liquid to the microdialysis probe whereby the perfusion liquid is enriched with the metabolite contained in the lymph;

removing the enriched perfusion liquid as a dialysate from the microdialysis probe;

adding an enzyme in the form of an enzyme solution continuously to the dialysate in an amount based on the flow rate of the dialysate to form a dialysate measurement solution;

determining the concentration of the metabolite in the dialysate by measuring the dialysate measurement solution ex vivo with an electrochemical sensor; and

determining the concentration of the metabolite in the biological tissue based on the concentration of the metabolite in the dialysate.

2. The method of claim 1, wherein the metabolite in the measurement solution dialysate is oxidized by the action of the enzyme and the concentration of a reaction partner participating in or resulting from the oxidation of the metabolite is amperometrically determined by two polarized electrodes of the sensor.

3. The method of claim 2, further comprising the step of separating the electrodes of the sensor from the dialysate measurement solution by way of a removable dialysis membrane which is permeable to the reaction partner and impermeable to the enzyme.

4. The method of claim 1, wherein the ratio of the perfusion fluid flow rate to the enzyme solution flow rate lies in the range of 1:

10 to 10;

1.

5. The method of claim 4, wherein the ratio is 1:

1.

6. The method of claim 1, wherein the perfusion fluid flow rate is 0.1 to 15 μ

l/min.

7. The method of claim 6, wherein the perfusion flow rate is from 6 to 7 μ

l/min.

8. The method of claim 1, wherein the enzyme is glucose oxidase or lactate oxidase.

9. The method of claim 6, wherein the concentration of the enzyme in the enzyme solution is in the range of 100 U/ml to 10,000 U/ml.

10. The method of claim 1, wherein the perfusion fluid is buffered by a phosphate and is a physiological saline- or Ringer-solution.

11. The method of claim 1, wherein cresol is added to the enzyme solution in a concentration ranging from 0.01 to 1 percent by weight.

12. The method of claim 1, wherein at least one of the enzyme solution and the perfusion liquid is enriched with oxygen.

13. An apparatus for continuously monitoring the concentration of a metabolite in biological tissue comprising a microdialysis probe for implantation in subcutaneous tissue;

means for feeding a perfusion liquid to the microdialysis probe comprising a perfusion liquid reservoir, a first transport means for providing a flow of the perfusion liquid from the perfusion liquid reservoir to the microdialysis probe and a perfusion liquid tube for carrying the perfusion liquid from the first transport means to the microdialysis probe;

a dialysate tube for removing a perfusion liquid enriched with the metabolite from the microdialysis probe;

an enzyme solution reservoir containing an enzyme solution;

a feed channel for carrying the enzyme solution to a junction formed by said feed channel and said dialysate tube where the enriched perfusion liquid and the enzyme solution are intermixed with each other to form a dialysate measurement solution;

an ex vivo measuring device comprising a sensor for determining the concentration of the metabolite in the dialysate measurement solution, a second transport means for providing a constant flow of the dialysate measurement solution to the ex vivo measuring device and a dialysate measurement solution tube for carrying the dialysate measurement solution from the junction to the ex vivo measuring device.

14. The apparatus of claim 13, wherein the flow capacity of the second transport means is larger than the flow capacity of the first transport means.

15. The apparatus of claim 14, wherein the flow capacity of the second transport means is twice that of the first transport means.

16. The apparatus of claim 13, wherein the first and second transport means are metering pumps.

17. The apparatus of claim 16, wherein the metering pumps are rolling pumps or piston pumps.

18. The apparatus of claim 13, wherein the first and second transport means are positioned in the perfusion liquid and dialysate measurement solution tubes and are tubes of a single rolling pump which are compressed by a mutual roller.

19. The apparatus of claim 13, wherein the sensor extends into a flow chamber of the dialysate measurement solution tube and is designed for amperometric measurements, said sensor comprising a measuring electrode consisting of platinum or gold and a comparative electrode consisting of silver or stainless steel positioned adjacent to the measuring electrode.

20. The apparatus of claim 19, wherein the sensor additionally comprises a removable semipermeable protection membrane which separates the measuring and comparative electrodes from the dialysate measurement solution.

21. The apparatus of claim 19, wherein temperature control means regulate the temperature in the flow chamber to a preset value in the range of 20°

C. to 35°

C.

22. The apparatus of claim 19, wherein means are provided for measuring the temperature of at least one of the dialysate measurement solution and the flow chamber and for compensating for the effect of the temperature on a signal from the sensor by calculating a correction factor.

23. The apparatus of claim 13, wherein a check valve which self-locks upon backflow of the dialysate measurement solution in the direction of the microdialysis probe is positioned in the dialysate tube.

24. The apparatus of claim 13, wherein the measuring device is portable and comprises microprocessor-controlled analyzing electronics which record a signal from the sensor and generate therefrom digital data correlated with the concentration of the metabolite in the tissue.

25. The apparatus of claim 24, wherein the measuring device comprises storage means for storing the data at constant intervals and display means for displaying the data.

26. The apparatus of claim 25, wherein the display means is an LCD-display.

27. The apparatus according to claim 13, additionally comprising automatic insulin-infusion means for compensating diabetical defects in diabetic patients, wherein insulin infusion is controlled according to the measured glucose level in the tissue of the patient.

28. In a method for continuously monitoring the concentration of glucose in the tissue of a patient and compensating for diabetical defects in the patient by automatic insulin infusion means wherein insulin infusion is controlled according to the glucose level measured in the tissue of the patient, the improvement comprising the concentration of the glucose in the tissue of the patient being continuously monitored by a method comprising the steps of:

implanting a microdialysis probe in subcutaneous tissue of the patient so that it contacts with lymph contained in the subcutaneous tissue;

feeding a perfusion liquid to the microdialysis probe whereby the perfusion liquid is enriched with glucose contained in the lymph;

removing the enriched perfusion liquid as a dialysate from the microdialysis probe;

adding an enzyme in the form of an enzyme solution continuously to the dialysate in an amount based on the flow rate of the dialysate to form a dialysate measurement solution;

determining the concentration of the glucose in the dialysate by measuring the dialysate measurement solution ex vivo with an electrochemical sensor; and

determining the concentration of the glucose in the tissue of the patient based on the concentration of the glucose in the dialysate.